ARC Group Limited is proud to announce the successful completion of a strategic divestment by Fresenius Medical Care AG (ETR: FME). The transaction involved the sale of Fresenius Medical Care’s equity interest in six hospital centers in China, owned by Jiangsu Fresenius Medical Care Hospital Management Services Co., Ltd., to Jiangxi Dakang Medical Management Co., Ltd. (“DiaCare Medical”). This move aligns with Fresenius Medical Care’s strategic objectives in China, optimizing its operational footprint while maintaining its focus on improving patient outcomes globally.
The divested assets include Hejiang Kangcheng Nephrosis Specialized Hospital, Kunming Wuhua Health Hospital, Ziyang Zhongxin Anorectal Hospital, Rong County Huakang Kidney Disease Hospital, Chongqing Rongchang Tangcheng Hospital, and Chongqing Rongchang Kangfuer Hospital. These facilities play a critical role in providing renal care services across several provinces in China.
Valentin Ischer, Managing Director at ARC Group, commented on the significance of the transaction: “This divestment represents an important milestone for Fresenius Medical Care and DiaCare Medical. By aligning the strengths of both organizations, we are helping to shape the future of renal care in China. ARC Group is proud to have facilitated this transaction, which reflects our commitment to delivering tailored solutions that meet the evolving needs of our clients in the healthcare sector.”
Sergio Camarero, President of ARC Group, added: “ARC Group is honored to have played a pivotal role in bridging the gap between East and West in facilitating this strategic acquisition. This transaction exemplifies the potential for collaboration between industry leaders to address the evolving healthcare needs of patients worldwide.”
This transaction aligns with Fresenius Medical Care’s broader strategy to streamline its portfolio while maintaining its leadership in the global renal care industry. By concentrating on its core competencies, the company is poised to further elevate the quality of its service offerings and expand access to its best-in-class renal care solutions. With a robust global network of over 4,000 dialysis clinics, Fresenius Medical Care remains at the forefront of delivering comprehensive care to its worldwide patient base.
Jiangxi Dakang Medical Management Co., Ltd., China’s leading provider of hemodialysis services, is well-positioned to expand its operations through this acquisition, with over 70 dialysis centers across 15 provinces already under its management. The company’s vision for growth aligns with the increasing demand for advanced renal care services in China.
ARC Group, along with Finanzas & Gestión (F&G), acted as financial advisors in the transaction. Their combined expertise in healthcare M&A was instrumental in navigating the complexities of the deal, ensuring alignment between the strategic interests of Fresenius Medical Care and DiaCare Medical.
The successful completion of this transaction reaffirms ARC Group’s position as a leading advisor in cross-border M&A and divestments, particularly within the healthcare sector. As Fresenius Medical Care and DiaCare Medical forge this strategic partnership, we expect a significant enhancement in renal care delivery across China. The collaboration is set to meet the rising demand for specialized healthcare services, positioning both parties to better serve a growing patient population with critical care needs.
About ARC Group
ARC Group is a global financial services and advisory firm specializing in mergers and acquisitions, SPACs, IPOs, and other financial advisory services. With a strong presence in Asia, the US, and Europe, ARC Group delivers comprehensive solutions tailored to the unique needs of each client. Trusted by Fortune 500 companies and industry leaders worldwide, ARC Group is recognized for its expertise in complex, cross-border transactions.
For more information or any questions, please contact:
Sergio Camarero
President
sergio.camarero@arc-group.com
For media inquiries, please contact:
Anna Sahlberg Carlsson
Marketing Manager
anna.sahlberg@arc-group.com
Ready to talk to one of our experts?
Contact us here for all your capital markets and M&A needs.
Not quite ready for an IPO yet? Our consulting division is here to help you prepare for the future.
Get in touch to explore how we can support your growth journey.
